Summit Therapeutics
SMMT
#2244
Rank
โ‚น737.35 B
Marketcap
โ‚น921.97
Share price
-5.87%
Change (1 day)
-36.44%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: โ‚น737.35 Billion

As of November 2026 Summit Therapeutics has a market cap of โ‚น737.35 Billion. This makes Summit Therapeutics the world's 2244th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น737.35 B-39.18%
2025โ‚น1.212 T5.23%
2024โ‚น1.152 T656.52%
2023โ‚น152.27 B115.08%
2022โ‚น70.80 B261.89%
2021โ‚น19.56 B-30.81%
2020โ‚น28.27 B268.89%
2019โ‚น7.66 B479.35%
2018โ‚น1.32 B-87.47%
2017โ‚น10.55 B47.62%
2016โ‚น7.15 B-23.64%
2015โ‚น9.36 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of Summit Therapeutics was reported to be:

โ‚น737.35 Billion
by Nasdaq info icon info icon
โ‚น737.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น132.45 B-82.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚น20.73 B-97.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚น5.29 B-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚น571.27 B-22.52%๐Ÿ‡บ๐Ÿ‡ธ USA